AU7683381A - Treatment of diabetes with biolin (vitamin-h) - Google Patents

Treatment of diabetes with biolin (vitamin-h)

Info

Publication number
AU7683381A
AU7683381A AU76833/81A AU7683381A AU7683381A AU 7683381 A AU7683381 A AU 7683381A AU 76833/81 A AU76833/81 A AU 76833/81A AU 7683381 A AU7683381 A AU 7683381A AU 7683381 A AU7683381 A AU 7683381A
Authority
AU
Australia
Prior art keywords
biolin
diabetes
vitamin
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU76833/81A
Other languages
English (en)
Inventor
John C. Coggeshall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CAPITAL MEDICAL ASSOCIATES
Original Assignee
CAPITAL MEDICAL ASS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CAPITAL MEDICAL ASS filed Critical CAPITAL MEDICAL ASS
Publication of AU7683381A publication Critical patent/AU7683381A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AU76833/81A 1980-10-27 1981-10-26 Treatment of diabetes with biolin (vitamin-h) Abandoned AU7683381A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20078480A 1980-10-27 1980-10-27
US200784 1980-10-27

Publications (1)

Publication Number Publication Date
AU7683381A true AU7683381A (en) 1982-05-06

Family

ID=22743169

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76833/81A Abandoned AU7683381A (en) 1980-10-27 1981-10-26 Treatment of diabetes with biolin (vitamin-h)

Country Status (6)

Country Link
JP (1) JPS5799520A (enrdf_load_stackoverflow)
AU (1) AU7683381A (enrdf_load_stackoverflow)
BE (1) BE890888A (enrdf_load_stackoverflow)
DE (1) DE3142590A1 (enrdf_load_stackoverflow)
FR (1) FR2492662A1 (enrdf_load_stackoverflow)
NL (1) NL8104818A (enrdf_load_stackoverflow)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE19855T1 (de) * 1982-03-01 1986-06-15 Efamol Ltd Pharmazeutische und diaetetische zusammensetzung.
AU2003266287A1 (en) * 2002-08-23 2004-03-11 Dsm Ip Assets B.V. Novel nutraceutical compositions comprising biotin
JP2004203863A (ja) * 2002-12-09 2004-07-22 Taisho Pharmaceut Co Ltd 抗糖尿病用組成物
JP2006089392A (ja) * 2004-09-22 2006-04-06 Tohoku Univ 生活習慣病改善食品および生活習慣病治療薬

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE788779A (fr) * 1971-09-13 1973-01-02 Magnor Inc Produit a base de biotine pour le traitement du diabete

Also Published As

Publication number Publication date
FR2492662A1 (fr) 1982-04-30
DE3142590A1 (de) 1982-08-12
BE890888A (fr) 1982-02-15
NL8104818A (nl) 1982-05-17
JPS5799520A (en) 1982-06-21
FR2492662B1 (enrdf_load_stackoverflow) 1985-04-19

Similar Documents

Publication Publication Date Title
AU551401B2 (en) Blood dilvent
AU552422B2 (en) Syringe
AU554672B2 (en) Treatment of osteitis
AU543883B2 (en) Topical hyperboric oxygen chamber medical
AU7654581A (en) 2-amino-6-trifluoromethoxy-benzothiazole medicament
AU546858B2 (en) s
AU543210B2 (en) Peripheral processor architecture
AU544280B2 (en) Feminine syringe
AU537587B2 (en) Blood oxygenator
AU7566481A (en) Treatment of water with oxygen
AU552082B2 (en) Treatment of polysaccharide solutions
AU5397579A (en) Purifying insulin
JPS5775919A (en) Diabetes complication treating agent
AU524741B2 (en) Treatment of wood
AU520090B2 (en) Alcoholic content of blood
AU7683381A (en) Treatment of diabetes with biolin (vitamin-h)
AU546879B2 (en) Improved glass fibre treatment
JPS56154443A (en) Manufacture of insulin
AU7311481A (en) Patient hoist
AU535970B2 (en) Perfluoroamides of n-phosphonomethyl-glycinonitrile
AU6184480A (en) Coffins
AU528863B2 (en) Treatment of ulcers with bis-chromonyl compounds
AU561651B2 (en) Physiological electrode system
AU6958781A (en) Treatment of yarn
AU515919B2 (en) Treatment of liquids